SCHEMBL7474547

SCHEMBL7474547

COC(=O)c1ccc2c3c(n(Cc4ccccc4Cl)c2c1)CCCC3=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.52
HDAC6 Q9UBN7 3/20 0.52
DPP4 P27487 2/20 0.49
FABP4 P15090 1/20 0.44
MAPT P10636 4/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
HTR3A P46098 1/20 0.40
POLB P06746 1/20 0.39
PLA2G2A P14555 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7473427 0.94 DPP4 (0.46) HDAC1HDAC6DPP4FABP4MAPT
SCHEMBL7422336 0.88 FABP4 (0.57) HDAC1HDAC6DPP4FABP4ALDH1A1
SCHEMBL7428003 0.87 HDAC1 (0.54) HDAC1HDAC6DPP4FABP4TP53
SCHEMBL7422984 0.86 DPP4 (0.47) DPP4FABP4MAPTTP53LMNA
SCHEMBL7470778 0.82 DPP4 (0.46) DPP4MAPTTP53LMNAMAPK1
SCHEMBL7418839 0.82 FABP4 (0.54) HDAC1HDAC6DPP4FABP4ALDH1A1
SCHEMBL7414769 0.81 HDAC1 (0.46) HDAC1HDAC6DPP4FABP4TP53
SCHEMBL6694051 0.80 HDAC1 (0.44) HDAC1HDAC6DPP4MAPTTP53
SCHEMBL14895937 0.80 HDAC6 (0.75) HDAC1HDAC6PTGS1PTGS2
SCHEMBL7428023 0.76 MAPT (0.47) DPP4MAPTTP53LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed